HOXA-AS3 and pulmonary arterial hypertension: HOXA-AS3 was also overexpressed hypoxia-treated human pulmonary artery smooth muscle cells (HPASMCs), which was regarded as in vitro model of pulmonary arterial hypertension (PAH).